Cite
HARVARD Citation
Deng, Z. et al. (2023). Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies. Chinese medical journal. 136 (2), pp. 230-232. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Deng, Z. et al. (2023). Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies. Chinese medical journal. 136 (2), pp. 230-232. [Online].